down arrow

Alkem Lab

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE540L01014
  • NSEID: ALKEM
  • BSEID: 539523
INR
4,875.00
30.7 (0.63%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 28.45 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4,847.404,904.00

52 Week

4,409.906,440.00
Valuation
Technical
Day's Volume

CASH

28.45 k (-54.34%) Volume

Shareholding (Dec 2024)

FII

10.15%

Held by 460 FIIs

DII

18.01%

Held by 36 DIIs

Promoter

55.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 17.56%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 9.38% over the last 5 years

 
4

Flat results in Dec 24

5

Stock is technically in a Mildly Bearish range

6

With ROE of 19, it has a Attractive valuation with a 5 Price to Book Value

7

High Institutional Holdings at 28.16%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 58,288 Cr (Large Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.87%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

18.97%

stock-summary
Price to Book

5.04

Revenue and Profits (1 Year):
Net Sales:
3,374 Cr
(Quarterly Results - Dec 2024)
Net Profit:
626 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.87%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-21.12%
0.61%
-20.51%
1 Year
1.01%
0.88%
1.89%
2 Years
46.29%
2.47%
48.76%
3 Years
40.1%
3.89%
43.99%
4 Years
72.12%
5.07%
77.19%
5 Years
80.32%
7.17%
87.49%

Latest dividend: 37 per share ex-dividend date: Feb-14-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.38%
EBIT Growth (5y)
13.28%
EBIT to Interest (avg)
22.49
Debt to EBITDA (avg)
0.89
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.03
Tax Ratio
12.03%
Dividend Payout Ratio
26.63%
Pledged Shares
0
Institutional Holding
28.16%
ROCE (avg)
20.51%
ROE (avg)
17.56%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
33
Price to Book Value
5.04
EV to EBIT
26.02
EV to EBITDA
22.64
EV to Capital Employed
5.35
EV to Sales
4.48
PEG Ratio
1.00
Dividend Yield
0.87%
ROCE (Latest)
20.21%
ROE (Latest)
18.97%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 28 Schemes (14.01%)

FIIs

Held by 460 FIIs (10.15%)

Promoter with highest holding

Sarandhar Singh* (please Refer Notes) (19.95%)

Highest Public shareholder

Icici Prudential Multi-asset Fund (3.65%)

Individual Investors Holdings

15.9%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 1.52% vs 9.31% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 5.19% vs 30.84% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,374.28",
          "val2": "3,323.87",
          "chgp": "1.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "759.39",
          "val2": "707.59",
          "chgp": "7.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "36.03",
          "val2": "25.46",
          "chgp": "41.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-51.31",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "625.82",
          "val2": "594.96",
          "chgp": "5.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.51%",
          "val2": "21.29%",
          "chgp": "1.22%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.60% vs 13.30% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 35.99% vs 97.88% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,446.49",
          "val2": "6,407.89",
          "chgp": "0.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,361.47",
          "val2": "1,135.92",
          "chgp": "19.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.25",
          "val2": "60.09",
          "chgp": "-4.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-57.66",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,233.80",
          "val2": "907.25",
          "chgp": "35.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.12%",
          "val2": "17.73%",
          "chgp": "3.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.91% vs 11.90% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 23.79% vs 64.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,820.77",
          "val2": "9,731.76",
          "chgp": "0.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,120.86",
          "val2": "1,843.51",
          "chgp": "15.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "93.28",
          "val2": "85.55",
          "chgp": "9.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-108.97",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,859.62",
          "val2": "1,502.21",
          "chgp": "23.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.60%",
          "val2": "18.94%",
          "chgp": "2.66%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.21% vs 9.08% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 82.47% vs -40.19% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12,667.58",
          "val2": "11,599.26",
          "chgp": "9.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,245.49",
          "val2": "1,609.45",
          "chgp": "39.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "112.41",
          "val2": "107.36",
          "chgp": "4.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-121.49",
          "val2": "-102.98",
          "chgp": "-17.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,795.77",
          "val2": "984.17",
          "chgp": "82.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.73%",
          "val2": "13.88%",
          "chgp": "3.85%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,374.28
3,323.87
1.52%
Operating Profit (PBDIT) excl Other Income
759.39
707.59
7.32%
Interest
36.03
25.46
41.52%
Exceptional Items
0.00
-51.31
100.00%
Consolidate Net Profit
625.82
594.96
5.19%
Operating Profit Margin (Excl OI)
22.51%
21.29%
1.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 1.52% vs 9.31% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 5.19% vs 30.84% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
6,446.49
6,407.89
0.60%
Operating Profit (PBDIT) excl Other Income
1,361.47
1,135.92
19.86%
Interest
57.25
60.09
-4.73%
Exceptional Items
0.00
-57.66
100.00%
Consolidate Net Profit
1,233.80
907.25
35.99%
Operating Profit Margin (Excl OI)
21.12%
17.73%
3.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.60% vs 13.30% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 35.99% vs 97.88% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
9,820.77
9,731.76
0.91%
Operating Profit (PBDIT) excl Other Income
2,120.86
1,843.51
15.04%
Interest
93.28
85.55
9.04%
Exceptional Items
0.00
-108.97
100.00%
Consolidate Net Profit
1,859.62
1,502.21
23.79%
Operating Profit Margin (Excl OI)
21.60%
18.94%
2.66%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.91% vs 11.90% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 23.79% vs 64.50% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
12,667.58
11,599.26
9.21%
Operating Profit (PBDIT) excl Other Income
2,245.49
1,609.45
39.52%
Interest
112.41
107.36
4.70%
Exceptional Items
-121.49
-102.98
-17.97%
Consolidate Net Profit
1,795.77
984.17
82.47%
Operating Profit Margin (Excl OI)
17.73%
13.88%
3.85%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 9.21% vs 9.08% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 82.47% vs -40.19% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Alkem Laboratories Ltd stock-summary
stock-summary
Alkem Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
Company Coordinates stock-summary
Company Details
Alkem House SenapatiBapat Marg, Lower Parel Mumbai Maharashtra : 400013
stock-summary
Tel: 91-22-39829999
stock-summary
http://www.alkemlabs.com
stock-summary
investors@alkem.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."